Align Technology Picks a P&G Healthcare Veteran as Its Next CEO
The Tempe clear-aligner giant’s CEO succession signals the orthodontic technology market is maturing, and that changes how Arizona patients should choose a provider.

Align Technology, the Tempe company whose Invisalign system has become shorthand for clear orthodontic treatment worldwide, just named its next president and chief executive officer: Jennifer L. Davis, who most recently ran Procter and Gamble’s Global Healthcare business, a multibillion-dollar portfolio spanning oral health and personal health brands. Davis joins Align as CEO-elect and Board member on November 2, effective in the top role on December 31, succeeding Joseph M. Hogan, who has led the company since 2015. Hogan will remain on the Board through a strategy session in June 2027 before retiring.
The appointment is not just a personnel change at a Fortune 500 company headquartered in the East Valley. It is a signal about where the most consequential dental technology of the past generation is headed, and what that means for the Arizona patients and professionals who rely on it every day.
From Growth Architecture to Commercial Execution
Hogan’s decade-long tenure was a growth story by almost any measure. He took a company that made one product (the Invisalign aligner) and expanded it into the company that now defines digital dentistry: the iTero intraoral scanner, the exocad CAD/CAM software platform, and an end-to-end workflow that allows orthodontists and general dentists to plan, execute, and track treatment digitally. The company Align became under his leadership was not a product company in the traditional sense. It was a platform business, and building that platform required a CEO who thought in terms of ecosystem growth, technology integration, and provider adoption.
The company Davis is inheriting looks different from that starting point. Align now controls a dominant share of the global clear-aligner market. Its technology has been validated across tens of millions of treated cases. Competitors exist, but the category was not invented by them. The challenge for the next chapter is not breaking new ground: it is deepening the value the platform delivers to providers and patients at commercial scale.
Davis’s 33-year career at P&G is a curriculum in exactly that kind of work. P&G’s oral health portfolio includes some of the most recognized brands in professional and consumer dentistry. Those brands do not compete primarily by introducing breakthrough science. They compete through clinical credibility, professional relationships, distribution discipline, and outcome evidence. She ran that business across a global portfolio. That is not a tech-founder skillset. It is a commercial-execution skillset, and it is precisely what a maturing platform company recruits when it transitions from building the category to owning it.
What Platform Maturity Means in the Dental Chair
There is a practical consequence here that tends to get lost in the language of corporate succession announcements. When Align was in growth mode, adding providers was the priority. Any certified orthodontist or dentist who wanted to offer Invisalign was valuable to the platform, regardless of how deeply they integrated with its tools. Volume mattered more than depth.
When a platform matures, the calculus shifts. Outcome consistency and provider quality become the marketing, because patient satisfaction and clinical results are what sustain a dominant market position over time. Expect the next chapter at Align to emphasize deeper provider certification programs, tighter integration between its treatment-planning software and practice-management systems, and more rigorous tracking of case outcomes. Davis’s instinct at P&G was to build loyalty through measurable clinical results and professional-channel relationships, not through promotional spend. That orientation will shape how Align interacts with the Arizona dental community going forward.
For the dental and orthodontic community in Arizona, this transition means the company supplying their core technology is about to reward platform engagement more directly. Providers who use the full Align stack, maintain strong case-acceptance data, and participate in outcome-tracking programs are positioned to benefit from that shift. Those who treat clear aligners as a commodity product, ordering from the platform without engaging its planning tools, will find the gap between their offering and the market’s expectations widening.
What This Means If You Are Choosing a Provider
The practical translation for any Arizonan evaluating orthodontic treatment right now is straightforward: the technology has matured to a point where provider skill and platform engagement matter more than the brand of aligner being used.
Ask about case volume. Align’s internal data consistently shows outcome quality improving significantly past certain case-volume thresholds. A provider who tracks how many cases they have completed, and in which complexity categories, is a provider who is engaged with the platform’s feedback mechanisms. A provider who cannot answer that question clearly is not.
Ask about the scanning and planning workflow. The iTero intraoral scanner is not interchangeable with physical impressions. It enables real-time treatment simulations, integrates with Invisalign’s AI-assisted planning tools, and allows meaningful outcome comparisons over the arc of treatment. Providers who have invested in that technology are operating in a different clinical environment than those who have not.
Ask how the practice tracks outcomes. Align has been building outcome-data infrastructure for several years. A provider who uses that data to refine case selection and refine their own protocols is bringing a fundamentally different level of care to each case. That difference will only become more visible as Align’s new leadership deepens the commercial value attached to outcome engagement.
The board of a company as analytically rigorous as Align does not hire a P&G healthcare CEO without a clear theory of what that background unlocks. The theory, in this case, is that the clear-aligner market is entering a phase where scale, clinical consistency, and professional-channel depth matter most. Arizona is one of the fastest-growing dental markets in the country, and the platforms Arizona providers use are evolving to reflect that. Patients who choose their provider on the basis of clinical engagement with those platforms will be the ones who benefit most from that evolution.
Who are Arizona’s best health professionals?
See the honors, or nominate the professional who belongs on the list.
Explore the Health rankings



